# EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE
> **ANDA213654** · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN LTD · Approved 2021-01-06
## Drug
- **FDA Application Number:** ANDA213654
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE
- **Generic name:** Empagliflozin
- **Active ingredients:** EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** LUPIN LTD
- **First approval:** 2021-01-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213654)
---
*MORVS · CC0 1.0*